In CLL, HIF-1α fosters different tumor-promoting mechanisms: it mediates the adaptation of leukemic cells to hypoxia, functions as a pro-survival factor and is implicated in drug-resistance mechanisms [6,8,24]. This evidence concerns the gene HIF1A and neoplasm.